[시장보고서]세계의 병원 감염성 폐렴(HAP) 예방 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2032년)

세계의 병원 감염성 폐렴(HAP) 예방 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2032년)

Hospital-Acquired Pneumonia Prevention Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

상품코드 : 1623926

리서치사 : Persistence Market Research

발행일 : 2025년 01월

페이지 정보 : 영문 229 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 7,421,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,838,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 12,621,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계 병원 감염성 폐렴(HAP) 예방 시장 규모는 2025년 218억 달러에 이르고, 2025-2032년의 예측 기간 동안 5.6%의 연평균 복합 성장률(CAGR)로 확대되어 2032년에는 320억 달러에 달할 전망입니다.

병원 감염성 폐렴(HAP) 예방 시장에는 의료 환경에서 발생하는 폐렴 발생률을 줄이기 위한 다양한 제품, 기술 및 서비스가 포함됩니다. 이러한 솔루션에는 첨단 의료기기, 효과적인 감염 관리 프로토콜, 혁신적인 약수처리, 강화된 위생 관리 등이 포함됩니다. 이 시장은 병원, 장기요양시설, 외래 수술센터 등 다양한 이해관계자들에게 서비스를 제공합니다. 성장의 원동력은 환자 안전에 대한 관심 증가, 의료비 증가, 감염 예방 기술의 발전입니다.

세계 병원 감염성 폐렴(HAP) 예방 시장을 주도하는 몇 가지 주요 요인이 있습니다. 전 세계적으로 병원 내 감염(HAI)이 증가함에 따라 효과적인 예방 전략의 필요성이 강조되고 있습니다. 비침습적 인공호흡기, 항균 코팅 의료기기 등 진단 도구 및 예방 관리 솔루션의 혁신이 시장 확대에 기여하고 있습니다. 감염 관리 규정 준수를 강조하는 규제 프레임워크는 시장 성장을 더욱 촉진할 것입니다. 또한, 의료 전문가와 조직의 환자 안전에 대한 인식이 높아짐에 따라 감염 예방 조치에 대한 투자가 증가하고 있습니다.

개인화된 헬스케어 솔루션에 대한 수요 증가와 감염 모니터링을 위한 디지털 헬스케어 기술 도입 증가로 인해 이 시장은 큰 기회를 창출하고 있습니다. 인공지능(AI)과 머신러닝(ML)을 진단 도구에 통합하여 병원 감염성 폐렴(HAP)의 조기 발견과 예방을 강화할 수 있습니다. 생분해성 소독제 등 비용 효율적이고 환경 친화적인 감염 관리 솔루션의 개발은 의료 분야의 지속가능성에 대한 관심이 높아짐에 따라 이에 대응하고 있습니다. 첨단 감염 예방 조치를 시행하기 위해 의료 기관과 기술 제공 업체와의 파트너십을 통해 시장 잠재력을 더욱 확대할 수 있습니다.

이 보고서는 전 세계 병원 감염성 폐렴(HAP) 예방 시장을 조사했으며, 제품 유형별/최종 사용자별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

영문목차

Persistence Market Research has recently published an extensive report on the global Hospital-Acquired Pneumonia Prevention Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

Hospital-Acquired Pneumonia Prevention Market Size (2025E): USD 21.8 Bn
Projected Market Value (2032F): USD 32.0 Bn
Global Market Growth Rate (CAGR 2025 to 2032): 5.6%

Hospital-Acquired Pneumonia Prevention Market - Report Scope:

The Hospital-Acquired Pneumonia Prevention Market encompasses a variety of products, technologies, and services aimed at reducing the incidence of pneumonia acquired in healthcare settings. These solutions include advanced medical devices, effective infection control protocols, innovative pharmaceutical treatments, and enhanced sanitation practices. The market serves diverse stakeholders, including hospitals, long-term care facilities, and ambulatory surgical centers. Growth is driven by the increasing focus on patient safety, rising healthcare expenditures, and technological advancements in infection prevention.

Market Growth Drivers:

Several key factors are driving the global Hospital-Acquired Pneumonia Prevention Market. The increasing prevalence of hospital-acquired infections (HAIs) globally underscores the need for effective prevention strategies. Innovations in diagnostic tools and preventive care solutions, such as non-invasive ventilators and antimicrobial-coated medical devices, contribute to market expansion. Regulatory frameworks emphasizing infection control compliance further propel market growth. Additionally, heightened awareness of patient safety among healthcare professionals and organizations has driven investments in infection prevention measures.

Market Restraints:

Despite promising growth prospects, the Hospital-Acquired Pneumonia Prevention Market faces challenges related to the high costs associated with advanced preventive solutions. Budget constraints in low-income healthcare settings limit the adoption of cutting-edge technologies. Additionally, the complexity of implementing comprehensive infection prevention protocols in under-resourced facilities poses challenges. The potential for the development of antibiotic-resistant pathogens adds another layer of complexity, requiring continuous innovation and investment in research and development to overcome these hurdles.

Market Opportunities:

The market presents significant opportunities driven by the growing demand for personalized healthcare solutions and the rising adoption of digital health technologies for infection monitoring. The integration of artificial intelligence (AI) and machine learning (ML) in diagnostic tools enhances early detection and prevention of hospital-acquired pneumonia. The development of cost-effective and eco-friendly infection control solutions, such as biodegradable disinfectants, caters to the growing focus on sustainability in healthcare. Partnerships between healthcare organizations and technology providers to implement advanced infection prevention measures further expand market potential.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the Hospital-Acquired Pneumonia Prevention Market globally?
Which types of products and services are leading the adoption in various healthcare settings?
How are technological advancements influencing the competitive landscape of the Hospital-Acquired Pneumonia Prevention Market?
Who are the key players in the Hospital-Acquired Pneumonia Prevention Market
What strategies are they employing to stay competitive?
What are the emerging trends and future prospects in the global Hospital-Acquired Pneumonia Prevention Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Hospital-Acquired Pneumonia Prevention Market, including 3M, Becton, Dickinson and Company, and Medtronic, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced preventive care solutions and explore new applications for existing products. Collaborations with healthcare providers, government bodies, and research organizations facilitate the implementation of effective infection prevention strategies. Emphasis on consumer education, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Hospital-Acquired Pneumonia Prevention Market landscape.

Key Companies Profiled:

Sage Products LLC (Stryker Corporation)
Intersurgical Ltd.
Medline Industries, Inc.
Halyard Health, Inc.
Others.

Hospital-Acquired Pneumonia Prevention Market Industry Segmentation:

Segmentation by Product Type

Oral Care Kit
Toothbrush
Swab
Moisturizer
Mouth Wash
Suction Tools

Segmentation by End-user

Hospitals
Rehabilitation Centers
Home Care Settings

Segmentation by Region

North America
Latin America
Europe
Asia Pacific excluding China (APEC)
China
Middle East & Africa (MEA)

1. Executive Summary

1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Definition
2.2. Market Taxonomy

3. Hospital-Acquired Pneumonia Prevention Market Opportunity Analysis

3.1. Macro-Economic Factors
3.2. Opportunity Analysis

4. Market Background

4.1. Market Dynamics
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Global Trends
4.2. Hospital-Acquired Pneumonia - Etiology Assessment
4.3. Hospital-Acquired Pneumonia Pathogenesis
4.4. Value Chain Analysis
4.5. Parent Market Analysis
4.6. Supply Demand Analysis (Gap Analysis)
4.7. Regional Cost of Care Analysis

5. Global Economic Outlook

5.1. Gross Domestic Therapy by Region & Country, 2025 - 2032
5.2. Global Healthcare Outlook

6. North America Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032

6.1. Introduction
6.2. Key Market Trends
6.3. Historical Market Size (US$ Bn) Analysis By Country, 2020 - 2024
- 6.3.1. U.S.
- 6.3.2. Canada
6.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
6.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2020 - 2024
- 6.5.1. Oral Care Kits
- 6.5.2. Toothbrush
- 6.5.3. Swab
- 6.5.4. Moisturizer
- 6.5.5. Mouthwash
- 6.5.6. Suction Tools
6.6. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
6.7. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
- 6.7.1. Hospitals
- 6.7.2. Rehabilitation Centers
- 6.7.3. Home Care Settings
6.8. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
6.9. Market Attractiveness Analysis
- 6.9.1. By Country
- 6.9.2. By Product Type
- 6.9.3. By End User
6.10.Drivers and Restraints - Impact Analysis

7. Latin America Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032

7.1. Introduction
7.2. Key Market Trends
7.3. Historical Market Size (US$ Bn) Trends Analysis By Country, 2020 - 2024
- 7.3.1. Argentina
- 7.3.2. Brazil
- 7.3.3. Mexico
- 7.3.4. Rest of Latin America
7.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
7.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2020 - 2024
- 7.5.1. Oral Care Kits
- 7.5.2. Toothbrush
- 7.5.3. Swab
- 7.5.4. Moisturizer
- 7.5.5. Mouthwash
- 7.5.6. Suction Tools
7.6. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
7.7. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
- 7.7.1. Hospitals
- 7.7.2. Rehabilitation Centers
- 7.7.3. Home Care Settings
7.8. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
7.9. Market Attractiveness Analysis
- 7.9.1. By Country
- 7.9.2. By Product Type
- 7.9.3. By End User
7.10.Drivers and Restraints - Impact Analysis

8. Europe Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032

8.1. Introduction
8.2. Key Market Trends
8.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
- 8.3.1. Germany
- 8.3.2. U.K.
- 8.3.3. France
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Poland
- 8.3.8. Rest of Europe
8.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
8.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2020 - 2024
- 8.5.1. Oral Care Kits
- 8.5.2. Toothbrush
- 8.5.3. Swab
- 8.5.4. Moisturizer
- 8.5.5. Mouthwash
- 8.5.6. Suction Tools
8.6. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
8.7. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
- 8.7.1. Hospitals
- 8.7.2. Rehabilitation Centers
- 8.7.3. Home Care Settings
8.8. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
8.9. Market Attractiveness Analysis
- 8.9.1. By Country
- 8.9.2. By Product Type
- 8.9.3. By End User
8.10. Drivers and Restraints - Impact Analysis

9. Asia Pacific Excluding China Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032

9.1. Introduction
9.2. Key Market Trends
9.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
- 9.3.1. Japan
- 9.3.2. India
- 9.3.3. Australia and New Zealand
- 9.3.4. Rest of Asia Pacific
9.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
9.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2020 - 2024
- 9.5.1. Oral Care Kits
- 9.5.2. Toothbrush
- 9.5.3. Swab
- 9.5.4. Moisturizer
- 9.5.5. Mouthwash
- 9.5.6. Suction Tools
9.6. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
9.7. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
- 9.7.1. Hospitals
- 9.7.2. Rehabilitation Centers
- 9.7.3. Home Care Settings
9.8. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
9.9. Market Attractiveness Analysis
- 9.9.1. By Country
- 9.9.2. By Product Type
- 9.9.3. By End User
9.10. Drivers and Restraints - Impact Analysis

10. China Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032

10.1. Introduction
10.2. Key Market Trends
10.3. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2020 - 2024
- 10.3.1. Oral Care Kits
- 10.3.2. Toothbrush
- 10.3.3. Swab
- 10.3.4. Moisturizer
- 10.3.5. Mouthwash
- 10.3.6. Suction Tools
10.4. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
10.5. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
- 10.5.1. Hospitals
- 10.5.2. Rehabilitation Centers
- 10.5.3. Home Care Settings
10.6. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
10.7. Market Attractiveness Analysis
- 10.7.1. By Country
- 10.7.2. By Product Type
- 10.7.3. By End User
10.8. Drivers and Restraints - Impact Analysis

11. Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032

11.1. Introduction
11.2. Key Market Trends
11.3. Historical Market Size (US$ Bn) Trend Analysis By Country, 2020 - 2024
- 11.3.1. GCC Countries
- 11.3.2. South Africa
- 11.3.3. Rest of MEA
11.4. Market Size (US$ Bn) Forecast By Country, 2025 - 2032
11.5. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2020 - 2024
- 11.5.1. Oral Care Kits
- 11.5.2. Toothbrush
- 11.5.3. Swab
- 11.5.4. Moisturizer
- 11.5.5. Mouthwash
- 11.5.6. Suction Tools
11.6. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
11.7. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
- 11.7.1. Hospitals
- 11.7.2. Rehabilitation Centers
- 11.7.3. Home Care Settings
11.8. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
11.9. Market Attractiveness Analysis
- 11.9.1. By Country
- 11.9.2. By Product Type
- 11.9.3. By End User
11.10. Drivers and Restraints - Impact Analysis

12. Forecast Assumptions

13. Competition Analysis

13.1. Company Share Analysis (2024)
13.2. Competition Dashboard
13.3. Company Deep Dive
- 13.3.1. Sage Products LLC (Stryker Corporation)
  - 13.3.1.1. Overview
  - 13.3.1.2. Product Portfolio
  - 13.3.1.3. Sales Footprint
  - 13.3.1.4. Strategy
    - 13.3.1.4.1. Marketing Strategy
    - 13.3.1.4.2. Therapy Strategy
    - 13.3.1.4.3. Channel Strategy
- 13.3.2. Intersurgical Ltd.
  - 13.3.2.1. Overview
  - 13.3.2.2. Product Portfolio
  - 13.3.2.3. Sales Footprint
  - 13.3.2.4. Strategy
    - 13.3.2.4.1. Marketing Strategy
    - 13.3.2.4.2. Therapy Strategy
    - 13.3.2.4.3. Channel Strategy
- 13.3.3. Medline Industries, Inc.
  - 13.3.3.1. Overview
  - 13.3.3.2. Product Portfolio
  - 13.3.3.3. Sales Footprint
  - 13.3.3.4. Strategy
    - 13.3.3.4.1. Marketing Strategy
    - 13.3.3.4.2. Therapy Strategy
    - 13.3.3.4.3. Channel Strategy
- 13.3.4. Halyard Health, Inc.
  - 13.3.4.1. Overview
  - 13.3.4.2. Product Portfolio
  - 13.3.4.3. Sales Footprint
  - 13.3.4.4. Strategy
    - 13.3.4.4.1. Marketing Strategy
    - 13.3.4.4.2. Therapy Strategy
    - 13.3.4.4.3. Channel Strategy

14. Global Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032, By Region

14.1. Introduction/Key Findings
14.2. Historical Market Size (US$ Bn) Trend Analysis By Region, 2020 - 2024
14.3. Market Size (US$ Bn) Forecast By Region, 2025 - 2032
- 14.3.1. North America
- 14.3.2. Latin America
- 14.3.3. Europe
- 14.3.4. Asia Pacific Excluding China
- 14.3.5. China
- 14.3.6. Middle East & Africa
14.4. Market Attractiveness Analysis By Region

15. Global Hospital-Acquired Pneumonia Prevention Analysis 2020 - 2024 and Forecast 2025 - 2032, By Product Type

15.1. Introduction/Key Findings
15.2. Historical Market Size (US$ Bn) Trend Analysis By Product Type, 2020 - 2024
- 15.2.1. Oral Care Kits
- 15.2.2. Toothbrush
- 15.2.3. Swab
- 15.2.4. Moisturizer
- 15.2.5. Mouthwash
- 15.2.6. Suction Tools
15.3. Market Size (US$ Bn) Forecast By Product Type, 2025 - 2032
15.4. Market Attractiveness Analysis By Product Type

16. Global Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032, By End User

16.1. Introduction/Key Findings
16.2. Historical Market Size (US$ Bn) Trend Analysis By End User, 2020 - 2024
- 16.2.1. Hospitals
- 16.2.2. Rehabilitation Centers
- 16.2.3. Home Care Settings
16.3. Market Size (US$ Bn) Forecast By End User, 2025 - 2032
16.4. Market Attractiveness Analysis By End User

17. Global Hospital-Acquired Pneumonia Prevention Market Analysis 2020 - 2024 and Forecast 2025 - 2032

17.1. Market Value Share Analysis By All Segment
17.2. Y-o-Y Growth Analysis By All Segment
17.3. Absolute $ Opportunity

한글목차

목차

제1장 주요 요약

제2장 시장 서론

제3장 병원 감염성 폐렴(HAP) 예방 시장 기회 분석

제4장 시장 배경

제5장 세계 경제 전망

제6장 북미의 병원 감염성 폐렴(HAP) 예방 시장 분석(2020년-2024년) 및 예측(2025년-2032년)

제7장 라틴아메리카의 병원 감염성 폐렴(HAP) 예방 시장 분석(2020년-2024년) 및 예측(2025년-2032년)

제8장 유럽의 병원 감염성 폐렴(HAP) 예방 시장 분석(2020년-2024년) 및 예측(2025년-2032년)

제9장 중국을 제외한 아시아태평양의 병원 감염성 폐렴(HAP) 예방 시장 분석(2020년-2024년) 및 예측(2025년-2032년)

제10장 중국의 병원 감염성 폐렴(HAP) 예방 시장 분석(2020년-2024년) 및 예측(2025년-2032년)

제11장 중동 및 아프리카의 병원 감염성 폐렴(HAP) 예방 시장 분석(2020년-2024년) 및 예측(2025년-2032년)

제12장 예측의 전제조건

제13장 경쟁 분석

제14장 세계의 병원 감염성 폐렴(HAP) 예방 시장 분석(2020년-2024년) 및 예측(2025년-2032년), 지역별

제15장 세계의 병원 감염성 폐렴(HAP) 예방 분석(2020년-2024년) 및 예측(2025년-2032년), 제품 유형별

제16장 세계의 병원 감염성 폐렴(HAP) 예방 시장 분석(2020년-2024년) 및 예측(2025년-2032년), 최종사용자별

제17장 세계의 병원 감염성 폐렴(HAP) 예방 시장 분석(2020년-2024년) 및 예측(2025년-2032년)

제18장 사용된 전제조건과 두자어

제19장 조사 방법